Published Date: 01 Aug 2025
A new study reveals that some men who are diagnosed with "Grade Group one" (GG1) prostate cancer may actually be at higher risk than biopsy results suggest, according to research led by Weill Cornell Medicine, University ...
Read Full NewsCancer patients aren't just battling a deadly disease—part of their time and energy can also be spent fighting the system intended to cure them, a new study says. The findings are published in the journal JCO Oncology Practice.
October is Breast Cancer Awareness Month, and cancer awareness starts with general breast awareness. Dr. Julie Nangia, medical director of breast oncology at the Dan L Duncan Comprehensive Cancer Center, recommends monthly ...
A multicenter study led by London Health Sciences Centre Research Institute (LHSCRI), Lawson Research Institute of St. Joseph's Health Care London (Lawson), and University Health Network (UHN) has found a novel imaging solution, ...
Loneliness and social isolation are linked to a heightened risk of death from cancer as well as from all causes among those with the disease, finds a pooled data analysis of the available research published online in the ...
1.
Mixed Results With Cyclophosphamide in Mismatched Unrelated Stem Cell Transplants
2.
Men With Prostate Cancer Experience Less Hot Flashes When Using an Affordable Drug.
3.
AI can identify women at risk of breast cancer years in advance: Study
4.
Researchers discover that children who survive cancer have socioeconomic challenges.
5.
In MDS at Lower Risk, Novel Therapy Diminished Transfusion Dependency.
1.
The Revolutionary Treatment of Hodgkin's Lymphoma: A New Hope for the Future
2.
Understanding Adenomyosis: The Role of Ultrasound in Diagnosis Introduction
3.
New Research on Craniopharyngioma
4.
Machine Learning in Hematology: Boosting Diagnostic Precision and Speed in Medical Practice
5.
Uncovering the Hidden Symptoms of Parathyroid Cancer in Women
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
2.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion
3.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
4.
Cost Burden/ Burden of Hospitalization For R/R ALL Patients
5.
Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation